
US FDA approves Sanofi's genetic disorder drug
来源:Reuters发布于 2026-11-18
The US FDA on Wednesday approved Sanofi's oral drug venglustat, making it the first treatment for a type of rare genetic condition that affects the brain and nervous system, the health regulator sai...
相关标的:SNY
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。